539730
FREDUN
Invest Now
Start SIP in
FREDUN
Performance
- Low
- ₹662
- High
- ₹697
- 52 Week Low
- ₹635
- 52 Week High
- ₹1,024
- Open Price₹697
- Previous Close₹690
- Volume5,014
Investment Returns
- Over 1 Month -5.21%
- Over 3 Month -4.68%
- Over 6 Month -8.46%
- Over 1 Year -19.08%
Smart Investing Starts Here Start SIP with Fredun Pharmaceuticals for Steady Growth!
Fredun Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 16.8
- PEG Ratio
- 0.6
- Market Cap Cr
- 315
- P/B Ratio
- 2.4
- Average True Range
- 25.55
- EPS
- -
- Dividend Yield
- 0.1
- MACD Signal
- -3.8
- RSI
- 52.62
- MFI
- 58.03
Fredun Pharmaceuticals Financials
Fredun Pharmaceuticals Technicals
EMA & SMA
Current Price
₹667.40
-22.25
(-3.23%)

-
- Bearish Moving Average 16
-
- Bullish Moving Average 0
- 20 Day
- ₹681.41
- 50 Day
- ₹687.94
- 100 Day
- ₹703.36
- 200 Day
- ₹736.24
Resistance and Support
691.55
- R3 728.10
- R2 716.55
- R1 703.10
- S1 678.10
- S2 666.55
- S3 653.10
Fredun Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-02-04 | Quarterly Results | |
2024-10-26 | Quarterly Results | |
2024-10-03 | Others | inter alia consider issue and allotment of Unsecured Foreign Currency ConvertibleBonds (FCCBs), in accordance with the provisions of the SEBI Regulations, 2018 and the Companies Act, 2013. alia, to consider a proposal for fund raising up to Rs.120 crores by way of further public offer, rights issue, debt issue, preferential issue or any other method. |
2024-07-29 | Quarterly Results | |
2024-05-07 | Audited Results & Final Dividend |
Fredun Pharmaceuticals F&O
About Fredun Pharmaceuticals
- NSE Symbol
- FREDUN
- BSE Symbol
- 539730
- Managing Director & CFO
- Mr. Fredun Medhora
- ISIN
- INE194R01017
Similar Stocks to Fredun Pharmaceuticals
Fredun Pharmaceuticals FAQs
Fredun Pharmaceuticals share price is ₹667 As on 25 April, 2025 | 16:44
The Market Cap of Fredun Pharmaceuticals is ₹315.1 Cr As on 25 April, 2025 | 16:44
The P/E ratio of Fredun Pharmaceuticals is 16.8 As on 25 April, 2025 | 16:44
The PB ratio of Fredun Pharmaceuticals is 2.4 As on 25 April, 2025 | 16:44
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.